Your browser doesn't support javascript.
loading
Radiotherapy Delivered before CDK4/6 Inhibitors Mediates Superior Therapeutic Effects in ER+ Breast Cancer.
Petroni, Giulia; Buqué, Aitziber; Yamazaki, Takahiro; Bloy, Norma; Liberto, Maurizio Di; Chen-Kiang, Selina; Formenti, Silvia C; Galluzzi, Lorenzo.
Affiliation
  • Petroni G; Department of Radiation Oncology, Weill Cornell Medical College, New York, New York.
  • Buqué A; Department of Radiation Oncology, Weill Cornell Medical College, New York, New York.
  • Yamazaki T; Department of Radiation Oncology, Weill Cornell Medical College, New York, New York.
  • Bloy N; Department of Radiation Oncology, Weill Cornell Medical College, New York, New York.
  • Liberto MD; Department of Pathology, Weill Cornell Medical College, New York, New York.
  • Chen-Kiang S; Department of Pathology, Weill Cornell Medical College, New York, New York.
  • Formenti SC; Graduate Program of Immunology and Microbial Pathogenesis, Weill Cornell Medical College, New York, New York.
  • Galluzzi L; Sandra and Edward Meyer Cancer Center, New York, New York.
Clin Cancer Res ; 27(7): 1855-1863, 2021 04 01.
Article in En | MEDLINE | ID: mdl-33495311
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Piperazines / Pyridines / Breast Neoplasms / Protein Kinase Inhibitors / Cyclin-Dependent Kinase 4 / Cyclin-Dependent Kinase 6 Type of study: Prognostic_studies Limits: Animals / Female / Humans Language: En Year: 2021 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Piperazines / Pyridines / Breast Neoplasms / Protein Kinase Inhibitors / Cyclin-Dependent Kinase 4 / Cyclin-Dependent Kinase 6 Type of study: Prognostic_studies Limits: Animals / Female / Humans Language: En Year: 2021 Type: Article